| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Juan Li, Zhao Yin, Zeming Yu, Jiannan Li, Lu Yan. Association Between Cannabis Use and Brain Structures: A Mendelian Randomization Study. Cureus. vol 16. issue 8. 2024-09-02. PMID:39221390. |
methods the genome-wide association studies (gwas) data for lifetime cannabis use (lcu), cannabis use disorder (cud), and brain cortical and subcortical structures were utilized in this study. |
2024-09-02 |
2024-09-04 |
Not clear |
| Namkee G Choi, C Nathan Marti, Bryan Y Cho. Associations between Cannabis Consumption Methods and Cannabis Risk Perception. International journal of environmental research and public health. vol 21. issue 8. 2024-08-29. PMID:39200597. |
along with medical use and cud, sociodemographic factors, mental illness, and other substance use were also significant correlates of cannabis consumption methods. |
2024-08-29 |
2024-09-01 |
Not clear |
| Kevin H Yang, Letitia Mueller, Omar El-Shahawy, Joseph J Palama. Cannabis Use, Use Disorder, and Workplace Absenteeism in the U.S., 2021-2022. American journal of preventive medicine. 2024-08-26. PMID:39186019. |
cannabis use and cannabis use disorder (cud) are associated with adverse psychosocial outcomes, but their impact on workplace absenteeism remains poorly understood. |
2024-08-26 |
2024-08-28 |
Not clear |
| Kevin H Yang, Letitia Mueller, Omar El-Shahawy, Joseph J Palama. Cannabis Use, Use Disorder, and Workplace Absenteeism in the U.S., 2021-2022. American journal of preventive medicine. 2024-08-26. PMID:39186019. |
this study aims to address these gaps by examining the associations between cannabis use recency, frequency, cud severity, and workplace absenteeism. |
2024-08-26 |
2024-08-28 |
Not clear |
| Leah K Hamilton, Katharine A Bradley, Theresa E Matson, Gwen T Lapha. Discriminative validity of a substance use symptom checklist for moderate-severe DSM-5 cannabis use disorder (CUD) in primary care settings. Drug and alcohol dependence reports. vol 12. 2024-08-19. PMID:39156656. |
discriminative validity of a substance use symptom checklist for moderate-severe dsm-5 cannabis use disorder (cud) in primary care settings. |
2024-08-19 |
2024-08-21 |
Not clear |
| Leah K Hamilton, Katharine A Bradley, Theresa E Matson, Gwen T Lapha. Discriminative validity of a substance use symptom checklist for moderate-severe DSM-5 cannabis use disorder (CUD) in primary care settings. Drug and alcohol dependence reports. vol 12. 2024-08-19. PMID:39156656. |
the prevalence of cannabis use disorder (cud) is increasing in the us and primary care providers need tools to identify patients with moderate-severe cud to facilitate treatment. |
2024-08-19 |
2024-08-21 |
Not clear |
| Leah K Hamilton, Katharine A Bradley, Theresa E Matson, Gwen T Lapha. Discriminative validity of a substance use symptom checklist for moderate-severe DSM-5 cannabis use disorder (CUD) in primary care settings. Drug and alcohol dependence reports. vol 12. 2024-08-19. PMID:39156656. |
a single-item screen for cannabis (sis-c) has outstanding discriminative validity for cud. |
2024-08-19 |
2024-08-21 |
Not clear |
| Leah K Hamilton, Katharine A Bradley, Theresa E Matson, Gwen T Lapha. Discriminative validity of a substance use symptom checklist for moderate-severe DSM-5 cannabis use disorder (CUD) in primary care settings. Drug and alcohol dependence reports. vol 12. 2024-08-19. PMID:39156656. |
however, because the prevalence of moderate-severe cud is typically low, the probability that an average patient who screens positive for daily cannabis has moderate-severe cannabis use disorder is low, making follow-up assessment important. |
2024-08-19 |
2024-08-21 |
Not clear |
| Namkee G Choi, John Moore, Bryan Y Cho. Cannabis use disorder and substance use treatment among U.S. adults. Journal of substance use and addiction treatment. 2024-08-16. PMID:39151799. |
recent expansion of cannabis legalization in multiple states calls for reexamination of the prevalence of cannabis use, cannabis use disorder (cud), and the associations between cud severity and substance use treatment. |
2024-08-16 |
2024-08-20 |
Not clear |
| Lydia A Shrier, Nicholas H McCaskill, Madeline C Smith, Madison M O'Connell, Brittany S Gluskin, Sarah Parker, Veronica Everett, Pamela J Burke, Sion Kim Harri. Telehealth counseling plus mHealth intervention for cannabis use in emerging adults: Development and a remote open pilot trial. Journal of substance use and addiction treatment. 2024-08-07. PMID:39111371. |
to improve treatment access for emerging adults with cannabis use disorder (cud), we developed a telehealth counseling-plus-mhealth intervention and remotely conducted a single-arm open pilot study to preliminarily evaluate its feasibility in primary care. |
2024-08-07 |
2024-08-10 |
Not clear |
| Shane A Tinsley, Sohrab Arora, Alex Stephens, Marco Finati, Giuseppe Chiarelli, Giuseppe Ottone Cirulli, Chase Morrison, Caleb Richard, Keinnan Hares, Craig G Rogers, Firas Abdolla. The impact of cannabis use disorder on urologic oncologic surgery morbidity, length of stay, and inpatient cost: analysis of the National Inpatient Sample from 2003 to 2014. World journal of urology. vol 42. issue 1. 2024-08-01. PMID:39090376. |
this study examined the impact of cannabis use disorder (cud) on inpatient morbidity, length of stay (los), and inpatient cost (ic) of patients undergoing urologic oncologic surgery. |
2024-08-01 |
2024-08-05 |
Not clear |
| Kelly C Young-Wolff, Felicia W Chi, Cynthia I Campbell, Monique B Does, Qiana L Brown, Stacey E Alexeeff, Deborah Ansley, Xiaoming Wang, Gwen T Lapha. Association of psychiatric and substance use disorders with cannabis use and cannabis use disorder during early pregnancy in northern California. Addiction (Abingdon, England). 2024-07-31. PMID:39082097. |
to estimate the strength of association between psychiatric disorders and substance use disorders (sud), and cannabis use and cannabis use disorder (cud) during early pregnancy. |
2024-07-31 |
2024-08-02 |
Not clear |
| Frances R Levin, John J Mariani, Martina Pavlicova, C Jean Choi, Cale Basaraba, Amy L Mahony, Daniel J Brooks, Christina A Brezing, Nasir Naqv. Extended-Release Mixed Amphetamine Salts for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cannabis Use Disorder: A Pilot, Randomized Double-Blind, Placebo-Controlled Trial. Journal of attention disorders. 2024-07-25. PMID:39051597. |
to determine if treatment of co-occurring adult adhd and cannabis use disorder (cud) with extended-release mixed amphetamine salts (mas-er) would be effective at improving adhd symptoms and promoting abstinence. |
2024-07-25 |
2024-07-28 |
Not clear |
| Christina A Brezing, Mohammad Sibai, C Jean Choi, Souparno Mitra, John J Mariani, Nasir Naqvi, Amy L Mahony, Daniel Brooks, Martina Pavlicova, Frances R Levi. Open Label Pilot of Lorcaserin (a serotonin 2C-receptor agonist) for Cannabis Use Disorder. Journal of substance use. vol 29. issue 4. 2024-07-18. PMID:39021751. |
cannabis use disorder (cud) has no fda approved treatment. |
2024-07-18 |
2024-07-20 |
human |
| Nikola Zaharakis, J Douglas Coatsworth, Nathaniel R Riggs, Aubrie Radford, Stephanie Rayburn, Jeremy Mennis, Michael A Russell, Aaron Brown, Michael J Maso. Treating young adult cannabis use disorder with text message-delivered peer network counseling. Contemporary clinical trials. 2024-07-17. PMID:39019156. |
approximately 16.5% of u.s. young adults have a cannabis use disorder (cud) and are at risk for negative outcomes. |
2024-07-17 |
2024-07-20 |
human |
| Alisa Stampf, Larissa Schwarzkopf, Albert Batalla, Daniel Feingold, Benedikt Fischer, Eva Hoc. Cannabis-related treatment demand at the eve of German cannabis legalization - a 20-years trend analysis. European archives of psychiatry and clinical neuroscience. 2024-07-01. PMID:38951248. |
treatment demand related to cannabis use disorder (cud) for the period 2001 to 2021 was investigated using data from the nation-wide standardized german addiction care statistical service. |
2024-07-01 |
2024-07-04 |
Not clear |
| Rupak Desai, Nitin Ghadge, Sai Gautham Kanagala, Nishanth Katukuri, Alpha James, Avinash Kadiyala, Sai Diksha Vutukuru, Meghana Kotharu, Tajdin Borzoo, Akhila Nalla, Ankit Vyas, Shivani Priyadarshni, Mostafa Shalaby, Wissam Khalif. Association of Cannabis Use Disorder With Hospitalizations for Pulmonary Embolism and Subsequent in-Hospital Mortality in Young Adults: A Contemporary Nationwide Analysis. Journal of the American Heart Association. 2024-06-27. PMID:38934855. |
with the increase in popularity of cannabis and its use and the lack of large-scale data on cannabis use and venous thromboembolism and pulmonary embolism (pe), we used a nationally representative cohort of young adults (aged 18-44 years) to compare the odds of admissions and in-hospital mortality of pe with and without cannabis use disorder (cud). |
2024-06-27 |
2024-06-29 |
Not clear |
| Mary F Brunette, Robert M Roth, Christi Trask, Jibran Y Khokhar, James C Ford, Soo Hwan Park, Sara M Hickey, Thomas Zeffiro, Haiyi Xi. Randomized Laboratory Study of Single-Dose Cannabis, Dronabinol, and Placebo in Patients With Schizophrenia and Cannabis Use Disorder. Schizophrenia bulletin. 2024-06-20. PMID:38900958. |
up to 43% of people with schizophrenia have a lifetime cannabis use disorder (cud). |
2024-06-20 |
2024-06-23 |
Not clear |
| Isaac C Rhew, Sabrina Oesterle, Margaret R Kuklinski, Katarina Guttmannova, Jennifer M Cadiga. The longitudinal association of cumulative depression with cannabis use disorder among young adults. Journal of studies on alcohol and drugs. 2024-06-20. PMID:38900055. |
this study examined whether the cumulative experience of elevated depressive symptoms from age 19 to 23 was associated with cannabis use disorder (cud) at age 26, and whether the association varied by perceived ease of access to cannabis and perceived risk for harms from cannabis use. |
2024-06-20 |
2024-06-22 |
Not clear |
| Alexis Blessing, Patricia D Russell, Madison S Stout, Juan Barerra-Barker, Sandra B Morissett. The Influence of Anxiety and Avoidant Coping on Probable Cannabis Use Disorder. Cannabis (Albuquerque, N.M.). vol 6. issue 4. 2024-06-17. PMID:38883279. |
individuals with anxiety frequently use cannabis to cope and are at greater risk for developing probable cannabis use disorder (cud). |
2024-06-17 |
2024-06-19 |
Not clear |